NCT04984681

Brief Summary

In our Supplement Aim we will conduct a two-arm randomized pilot test of the adapted intervention compared to a usual care control group among 30 African American/Black women with HIV (15/arm) to assess the feasibility and acceptability of the mindfulness-based stress reduction among women with HIV with mild cognitive impairment. Feasibility will be assessed by our ability to (1) recruit, randomize, and retain participants and (2) deliver the intervention per the manual, as well as (3) participants adherence to home practices and assignments. Acceptability will be assessed via qualitative data (focus group input regarding participants' satisfaction with the intervention and intent to continue using the practices), as well quantitative data (satisfaction survey).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable hiv-infections

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable hiv-infections

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 30, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

March 2, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2022

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

October 1, 2024

Completed
Last Updated

October 1, 2024

Status Verified

June 1, 2024

Enrollment Period

8 months

First QC Date

July 19, 2021

Results QC Date

December 13, 2023

Last Update Submit

June 19, 2024

Conditions

Keywords

HIVCisgender womenAfrican American or BlackMindfulness

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the Mindfulness Intervention in Women With Mild Cognitive Impairment

    Feasibility was measured using a four-item feasibility of intervention measure. Each item is scored using a Likert-like scale ranging from "1" completely disagree to "5" completely agree. Higher scores indicate greater feasibility. The minimum total score is 4 points, and the maximum total score is 20.

    Immediately after the intervention(which consists of an orientation followed by eight weekly sessions, consistent with MSBR interventions), the measure was collected within one week of completing the final session.

Study Arms (2)

Mindfulness-based Stress Reduction

EXPERIMENTAL

Mindfulness-based stress reduction sessions received by the treatment group will include an orientation, approximately 8 intervention sessions, and an exit interview.

Behavioral: Mindfulness

Usual Care

OTHER

The control condition will continue receiving usual care or standard of care.

Other: Usual Care

Interventions

MindfulnessBEHAVIORAL

The traditional mindfulness intervention consists of the following: (1) orientation; (2) a series of eight weekly session of 2.5 to 3 hours; (3) a silent retreat during the between weeks 4 and 6; (4) daily home assignments including formal and informal mindfulness practices; and (5) didactic presentations on stress and the consequences of stress.

Mindfulness-based Stress Reduction

The control condition will continue receiving usual care or standard of care.

Usual Care

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWe are recruiting cisgender females.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cisgender females
  • HIV seropositive
  • years of age or older
  • English speaking
  • An active patient at the local HIV ambulatory clinic in Alabama.
  • No history of neurological (including dementia diagnosis)
  • No history of severe psychiatric (e.g., schizophrenia or bipolar disorder) disorders

You may not qualify if:

  • Non-English speaking
  • Appear temporarily impaired (e.g., intoxicated)
  • Not willing to or legally unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UAB School of Nursing

Birmingham, Alabama, 35294, United States

Location

MeSH Terms

Conditions

HIV InfectionsCognitive Dysfunction

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Crystal Chapman Lambert
Organization
University of Alabama at Birmingham

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 19, 2021

First Posted

July 30, 2021

Study Start

March 2, 2022

Primary Completion

November 10, 2022

Study Completion

December 14, 2022

Last Updated

October 1, 2024

Results First Posted

October 1, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

The University of Alabama at Birmingham maintains the following universal data sharing policy for all investigators: 1. Data will be made available, in accordance with the NIH Data Sharing Policy (http://grants.nih.gov/grants/policy/data\_sharing) to all researchers in both the private and public sector free or for a nominal charge and with minimal restriction. In some cases the institution may determine that the public and the research community are better served by a licensing program whether or not patents have been filed. This may be relevant, for example, if a tool is best distributed under license to guarantee reagent availability and quality. 2. As a means of sharing knowledge, NIH encourages grantees to arrange for publication of NIH-supported original research in primary scientific journals. We therefore will strive to publish our findings in a timely manner and acknowledge that the research was supported by the NIH.

Locations